Sergio Stevanato inherited the operating platform founded by his father Giovanni and spent his career expanding it from a family glass-bottle maker into a global pharmaceutical-packaging group before the company listed in New York. [1][2]
He inherited a family manufacturing platform
Stevanato Group says Sergio is the son of founder Giovanni Stevanato and was involved in the family business from high school, so his starting point was an established operating company rather than a venture he founded independently. [1]
After earning a law degree in 1969, Sergio took leadership of the company and spent his career in the business, according to Stevanato's SEC filing. [1]
Forbes reports that the company began in 1949 making bottles for wine and perfume, shifted toward pharmaceutical glass packaging in the early 1970s and later expanded internationally through new plants and acquisitions. [2]
Decades of expansion multiplied the inherited base
By the time Stevanato Group listed on the New York Stock Exchange in 2021, it had become a major supplier of insulin cartridges, vials and syringes, and the IPO raised $672 million to finance further expansion. [2]
Forbes estimated that Sergio still owned 53% after the IPO, while his sons Franco and Marco held additional stakes and operating roles. His fortune therefore began with inherited family-company ownership but was materially expanded through decades of stewardship, internationalization and product development under later generations. [2][1]
Sources for background
Sources reviewed Sep 26, 2026.
- Annual Report on Form 20-F for 2025 · Stevanato Group S.p.A. · Mar 5, 2026
- The Italian Billionaire Family Making Glass Vials For Covid Vaccines Scores With U.S. IPO · Forbes · Jul 23, 2021
Comparable Healthcare billionaires
Similar Healthcare billionaires by estimated net worth.
